Group 1 - The core viewpoint of the article emphasizes the launch of the new floating fee rate product, Zhongyin Quality Emerging Mixed Fund, which aims to align with industry trends through a diversified performance benchmark [2][3] - The performance benchmark consists of 60% CSI 300 Index, 15% Hang Seng Index, 20% China Bond Composite Index, and 5% bank demand deposits, reflecting a comprehensive market trend across stocks and bonds [2][3] - The fund manager, Li Sijia, is noted for her balanced investment approach, focusing on multiple sources of returns to mitigate single beta exposure while aiming for stable risk-adjusted returns [2][3] Group 2 - Li Sijia has managed the Zhongyin Strategic Emerging Industries Stock Fund since October 2023, achieving a 43.92% return over the past year, significantly outperforming the benchmark return of 15.37% [3][5] - The article highlights Li Sijia's long-term optimism towards technology growth assets and cyclical industries, driven by strong industry trends and improving fundamentals [3] - The emergence of AI applications and related sectors, such as humanoid robots and semiconductors, is identified as a key investment opportunity, spurred by structural demand and technological advancements [3]

Core Viewpoint - The article discusses the launch of a new floating fee rate product, Zhongyin Quality Emerging Mixed Fund, which employs a unique management fee mechanism based on holding period and excess return rates [1]. Fund Overview - Zhongyin Quality Emerging Mixed Fund has a performance benchmark composed of 60% CSI 300 Index, 15% Hang Seng Index, 20% China Bond Composite Index, and 5% bank demand deposits, reflecting a diversified market trend [1]. - The fund aims to provide a reasonable performance reference for investors by covering both A-shares and Hong Kong stocks [1]. Fund Management - The fund will be managed by Li Sijia, who has a comprehensive background in cyclical, financial, and growth sectors, focusing on balanced investment strategies [1]. - Li Sijia aims to achieve stable risk-adjusted returns by diversifying income sources and avoiding single beta exposure [1]. Performance Review - Zhongyin Strategic Emerging Industry Stock A, managed by Li Sijia since October 2023, achieved a 43.92% return over the past year, significantly outperforming its benchmark of 15.37% [2]. - The fund has shown strong performance in recent years, with notable returns in 2020 (66.16%) and 2021 (25.75%), despite a downturn in 2022 (-19.96%) [4]. Market Outlook - Li Sijia expresses a long-term positive outlook on technology growth assets and cyclical industries, driven by strong industry trends and improvements in return on equity (ROE) [2]. - The article highlights the investment opportunities arising from the rapid growth of AI applications and the ongoing evolution of humanoid robotics, indicating a structural demand surge in related sectors [2]. Company Strategy - Zhongyin Fund aims to enhance its integrated investment research capabilities while providing diversified asset allocation solutions to improve investor experience [3].

Core Insights - The launch of the new floating fee rate product, Zhongyin Quality Emerging Mixed Fund, marks a significant development in the fund management industry, aligning with regulatory initiatives to enhance fund performance linkage to management fees [1][2] - The fund employs a unique floating management fee mechanism based on holding period and excess return, which is designed to incentivize performance and align interests between fund managers and investors [1][2] Fund Structure and Fee Mechanism - The floating management fee structure includes a 1.20% annual fee for holding periods under one year, while longer holding periods will have tiered fees of 0.60%, 1.20%, and 1.50% based on performance relative to a benchmark [1][2] - The performance benchmark for the fund consists of the CSI 300 Index (60%), Hang Seng Index (15%), China Bond Composite Index (20%), and bank demand deposits (5%), reflecting a diversified approach to performance measurement [2] Fund Management and Performance - The fund will be managed by Li Sijia, who has a comprehensive background in various sectors, aiming to achieve stable risk-adjusted returns through diversified income sources [2] - Li Sijia's previous management of the Zhongyin Strategic Emerging Industry Equity Fund yielded a 43.92% return over the past year, significantly outperforming the benchmark return of 15.37% [2][4] Market Context and Opportunities - The emergence of DeepSeek has triggered a global reassessment of Chinese tech assets, creating favorable conditions for sectors such as humanoid robots, artificial intelligence, and semiconductors [2] - The rapid growth of overseas AI applications is expected to drive investment opportunities in computing power-related sectors, indicating a structural demand surge [2]

Core Insights - A total of 19 public funds have launched their initial fundraising on August 4, including three products from the second batch of new floating-rate funds: E Fund Value Return Mixed, China Europe Core Select Mixed, and Jianxin Medical Innovation Stock [1] Fund Details - China Europe Core Select Mixed is set to end its fundraising on August 15, E Fund Value Return Mixed on August 20, and Jianxin Medical Innovation Stock on August 22 [1] - Jianxin Medical Innovation has a fundraising cap of 3 billion yuan [1] Fund Management - E Fund Value Return is managed by Tang Bolun, Jianxin Medical Innovation by Ma Muqing, and China Europe Core Select by Zhang Cong and Song Ting [1] Fund Approval and Themes - The second batch of new floating-rate funds was approved on July 24, covering various industry themes such as pharmaceuticals, manufacturing, and high-end equipment, along with initiator funds [1] - Among the new products, there are 2 stock-type funds and 10 equity-mixed funds, including: Invesco Great Wall High-end Equipment Stock, Jianxin Medical Innovation Stock, Bank of China Quality Emerging Mixed, Ping An Research-Driven Mixed, Southern Ruijing Mixed, Oriental Red Medical Innovation Mixed, E Fund Value Return Mixed, Huatai-PB Manufacturing Theme Mixed, Guotai Quality Core Mixed, China Europe Core Select Mixed, and Morgan Huikai Growth Mixed [1]

Core Viewpoint - The second batch of 11 floating fee rate new funds has been submitted for approval, expanding from the first batch of 26 funds, and includes both broad market selection products and industry-specific thematic products, particularly in sectors like pharmaceuticals, high-end equipment, and manufacturing [1][2]. Group 1: Fund Characteristics - The new floating fee rate funds are designed to meet investor demand for quality technology investment tools and leverage the research team's expertise in the technology growth sector [1][6]. - The second batch includes a diverse range of products, moving from broad market strategies to more specialized thematic strategies, indicating a richer variety of offerings to cater to different investor preferences [2][3]. - The management fee structure remains at three tiers: 1.2% (benchmark), 1.5% (upward adjustment), and 0.6% (downward adjustment), with specific conditions for fee application based on fund performance relative to benchmarks [2][3]. Group 2: Industry Focus - High-end equipment and pharmaceuticals are highlighted as key sectors for the new thematic funds, with high-end equipment being a core support of the modern industrial system and a significant part of technology investment [6]. - The pharmaceutical sector, particularly the innovative drug segment, is experiencing rapid revenue growth, with companies poised to enter international markets, indicating substantial future opportunities [6]. - The focus on biotechnology companies with global market potential and traditional pharmaceutical companies undergoing successful transformations is emphasized as a strategic investment direction [6].